Business Wire

CA-ALKIRA

27.4.2022 13:02:08 CEST | Business Wire | Press release

Share
Alkira Launches Free Tool to Tame Cloud Bloat

Cloud networking pioneer Alkira today launched Cloud Insights, a free tool to improve the networking and security of enterprise cloud deployments. Nearly a third (32%) of cloud spending is wasted, according to Flexera’s State of the Cloud Report 2022, which identifies optimization of existing cloud resources as the top priority for enterprises.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220427005119/en/

Cloud spending and network complexity accelerated during the pandemic, putting further pressure on businesses to optimize their cloud deployments. Growth shows no sign of slowing this year, as IDC forecasts a 21.7% increase in cloud infrastructure spending for the rest of 2022.

Alkira Cloud Insights helps cloud architects and networking admins regain control of their cloud infrastructure. The tool provides tailored recommendations on how to improve security, optimize spend and boost cloud networking performance in Amazon AWS and Microsoft Azure environments. It can help uncover duplicate IP addresses, unsanctioned internet access, unused networks and security resources, misconfigured security group settings, and unaccounted for shadow IT resources, among other things.

“Many organizations dramatically increased their cloud deployments at the beginning of Covid to support remote work and digital transformation,” said Amir Khan, CEO and founder of Alkira. “Because the shift was so sudden, many organizations' initial focus was on just making things work; the deployments were far from optimized. Alkira Cloud Insights allows businesses to do what equates to a bit of ‘spring cleaning’ for their environments. The tool helps to streamline cloud deployments, improve security posture and eliminate costly waste.”

Cloud Insights performs a rapid discovery of an organization’s AWS and Azure cloud networking environments. Companies will get a complete and automated inventory of their networking and security resources. They’ll also receive actionable data, including recommendations to improve cloud usage, security and spend. The insights and findings are delivered in an easy to use, centralized dashboard. There is also the ability to configure automated reporting to keep up to date on dynamic changes made to the cloud network environment.

Brad Casemore, Research Vice President, Datacenter and Multicloud Networks, IDC, said: “Networks that enable and support hybrid and multicloud should be sufficiently intelligent to perform optimally across an increasingly distributed landscape of cloud workloads and end points. But it all starts with meaningful audit and discovery, determining and understanding what workloads are running in which clouds, and providing insight into the networks and security postures associated with those workloads.

“Only with that foreknowledge can enterprises gain actionable insights that yield valuable business benefits and outcomes. With Cloud Insights, Alkira offers customers a free tool that helps to provide a foundational understanding of their cloud environments, setting the stage for informed enhancements that improve the agility, efficiency, performance, resiliency, and security of cloud networking.”

Existing customers get immediate access to Cloud Insights through the Alkira portal. The company is also making it freely available at https://www.alkira.com/cloud-insights to other enterprise teams looking for a quicker and easier way to audit their cloud estate.

About Alkira

Alkira is the leader in cloud networking as a service . We unify multiple clouds, sites, and users via an enterprise network built entirely in the cloud. Our Cloud Exchange Points auto-create this network plumbing and when deployed to multiple locations auto-connect to form a global fabric – all done with point and click integration of best-of-breed security and networking services. The network is managed using the same controls, policies, and security network admins know, can instantly scale as needed, and is available as a service. There is no new hardware to deploy, no software to download and no cloud architecture to learn. Alkira’s solution is trusted by Fortune 100 enterprises, leading system integrators and global managed service providers. Learn more at alkira.com and follow us @alkiranet .

Video Tour: https://youtu.be/jBQipdute44

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Pacific Defense Awarded U.S. Marine Corps Contract for Next Generation Electronic Warfare Prototype29.4.2026 13:00:00 CEST | Press release

Award advances SOSA/CMOSS mission system ecosystem and informs future EW fielding decisions Pacific Defense has been awarded a 12-month rapid prototyping contract by the U.S. Marine Corps Systems Command (MARCORSYSCOM), Program Manager for Tactical Communications and Electronic Warfare (PM TCE) to support next-generation electronic warfare (EW) capability evaluation. The effort will assess Modular Open Systems Approach (MOSA) Electronic Warfare (EW) mission systems and their potential in modernizing USMC capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429918712/en/ Pacific Defense's Next Generation Electronic Warfare System enables rapid integration of new hardware and software into a common chassis, accelerating capability insertion while reducing vendor lock and lifecycle costs. Under the contract, Pacific Defense will deliver SOSA/CMOSS-aligned mission systems to enable vehicle-based experimentation by U.S

Visa Accelerates Stablecoin Momentum: Adding Five Blockchains for Settlement29.4.2026 13:00:00 CEST | Press release

Stablecoin settlement pilot sees record growth 50% quarter over quarter, reaching $7B run rate. Today, Visa (NYSE: V) announced that it is adding five blockchains to its global stablecoin settlement pilot, expanding how issuers and acquirers can settle with the network. As stablecoins move into mainstream payment flows, Visa’s stablecoin settlement pilot now supports nine blockchains and has reached a $7 billion annualized stablecoin settlement run rate, up 50% since last quarter. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429143049/en/ Visa is adding support for five additional blockchains, further expanding its multi-chain settlement capabilities. “Our partners are building in a multi-chain world, and they expect their options to reflect that reality,” said Rubail Birwadker, Global Head of Growth Products and Strategic Partnerships, Visa. “Expanding our stablecoin settlement pilot program to more blockchains means o

U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA29.4.2026 12:00:00 CEST | Press release

TEVIMBRA plus ZIIHERA and chemotherapy regimen delivered statistically significant median OS of 26.4 months, an unprecedented result in this challenging diseaseResults from the global Phase 3 HERIZON-GEA-01 study demonstrate potential to change clinical practice in advanced HER2+ gastroesophageal adenocarcinoma BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to a supplemental Biologics License Application (sBLA) for TEVIMBRA® (tislelizumab) in combination with ZIIHERA® (zanidatamab) and chemotherapy for the first-line treatment of unresectable locally advanced/metastatic HER2-positive (HER2) gastric, gastroesophageal junction, or esophageal adenocarcinoma. The FDA has also granted Breakthrough Therapy Designation to the regimen of ZIIHERA in combination with fluoropyrimidine- and platinum-containing chemotherapy, with and without TEVIMBRA, in this indica

European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe29.4.2026 11:30:00 CEST | Press release

Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous use, the first and only approved biosimilar to PERJETA (pertuzumab) in Europe, for all indications of the reference product.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429686426/en/ “As the first, and currently the only, pertuzumab biosimilar in Europe, the EC’s approval of POHERDY marks an important milestone in expanding access to treatments for patients with certain HER2-positive breast cancers, particularly as breast cancer is the most commonly diagnosed cancer among women in the European Union,” said Joe Azzinaro, Vice President, Global Commercial Lead Biosimilars, at Organon.2,3 “Organon’s growing global portfolio of biosimilars reinforces our ongoing commitment to supporting the sustainability of healt

Andreas Goppelt Appointed Managing Director of OrphaCare29.4.2026 10:27:00 CEST | Press release

OrphaCare, a global specialist for the development and marketing of medical devices for drug delivery and part of the AOP Health Group, has appointed Andreas Goppelt as its new Managing Director, succeeding Georg Fischer. In this role, the seasoned medical device expert will focus on broadening the company’s strategic scope and driving its next phase of growth. OrphaCare plays a key role in supporting AOP Health’s integrated therapies approach, and the Group’s long-term expansion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429303533/en/ Portrait Andreas Goppelt, Managing Director OrphaCare (copyright: AOP Health/Studio Koekart) Andreas Goppelt brings more than 25 years of leadership experience across MedTech, biotechnology and the pharmaceutical industry. He has a proven track record of driving innovation, scaling global organizations, and delivering growth in highly regulated healthcare environments. In his new role,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye